- Home
- MEDP vs ITT Comparison
MEDP vs ITT Comparison
Compare MEDP & ITT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEDP
- ITT
- Stock Information
- Founded
- MEDP 1992
- ITT 1920
- Country
- MEDP United States
- ITT United States
- Employees
- MEDP N/A
- ITT N/A
- Industry
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- ITT Fluid Controls
- Sector
- MEDP Health Care
- ITT Industrials
- Exchange
- MEDP Nasdaq
- ITT Nasdaq
- Market Cap
- MEDP 10.5B
- ITT 11.6B
- IPO Year
- MEDP 2016
- ITT N/A
- Fundamental
- Price
- MEDP $311.23
- ITT $133.45
- Analyst Decision
- MEDP Buy
- ITT Strong Buy
- Analyst Count
- MEDP 10
- ITT 9
- Target Price
- MEDP $373.22
- ITT $168.38
- AVG Volume (30 Days)
- MEDP 404.9K
- ITT 570.2K
- Earning Date
- MEDP 04-21-2025
- ITT 05-01-2025
- Dividend Yield
- MEDP N/A
- ITT 1.05%
- EPS Growth
- MEDP 42.23
- ITT 27.01
- EPS
- MEDP 12.63
- ITT 6.30
- Revenue
- MEDP $2,109,054,000.00
- ITT $3,630,700,000.00
- Revenue This Year
- MEDP $4.45
- ITT $4.83
- Revenue Next Year
- MEDP $9.67
- ITT $5.02
- P/E Ratio
- MEDP $24.42
- ITT $21.18
- Revenue Growth
- MEDP 11.84
- ITT 10.59
- 52 Week Low
- MEDP $289.01
- ITT $121.01
- 52 Week High
- MEDP $459.77
- ITT $161.13
- Technical
- Relative Strength Index (RSI)
- MEDP 42.63
- ITT 44.97
- Support Level
- MEDP $289.01
- ITT $125.36
- Resistance Level
- MEDP $331.24
- ITT $142.11
- Average True Range (ATR)
- MEDP 9.98
- ITT 3.65
- MACD
- MEDP -1.51
- ITT -0.08
- Stochastic Oscillator
- MEDP 52.62
- ITT 48.30
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About ITT ITT Inc.
ITT Inc is a diversified manufacturer of engineered critical components and customized technology solutions predominantly for the transportation, industrial and energy markets. The company's products include, brake pads, shock absorbers, pumps, valves, connectors, switches and others. Its operating segments are; Motion Technologies (MT), Industrial Process (IP), and Connect & Control Technologies (CCT). The majority of the revenue is generated from the Motion Technologies segment which is a manufacturer of brake pads, shims, shock absorbers, energy absorption components and sealing technologies. Geographically, the company generates majority of the revenue from North America, and also has its presence in South America, Europe, Asia, Middle East and Africa.